To investigate the mechanisms underlying SDF-1-mediated EPC viability, EPCs (1x105 cells/well) were pretreated with CXCR4 antagonist AMD3100 (60 µM; Sigma-Aldrich; Merck KGaA), PI3K inhibitor LY294002 (20 µM; Selleck Chemicals) or MEK inhibitor PD98059 (20 µM; Sigma-Aldrich; Merck KGaA) for 2 h at 37˚C, and then stimulated with SDF-1 (100 ng/ml) for 24 h in 6-well plates at 37˚C with 5% CO2. EPCs were harvested and seeded (1x104 cells/well) into 96-well culture plates and incubated with SDF-1 (100 ng/ml) again for 48 h.
Cell proliferation was measured using the colorimetric MTS assay (Cell Titer 96 Aqueous; Promega Corporation), according to the manufacturer's protocol. MTS reagent (20 µl) was added to each well and incubated for 1 h at 37˚C. The optical density (OD) value of each well was measured at a wavelength of 490 nm using a 96-well plate reader (Bio-Rad Laboratories, Inc.).